Obstetrics/Gynecology
RSSArticles
-
Clinical Briefs in Primary Care Supplement
-
Pharmacology Watch: The FDA Pulls Another COX-2 Inhibitor Off the Market
The FDA has asked Pfizer to withdraw valdecoxib (Bextra) from the market due to safety concerns. -
Clinical Briefs in Primary Care supplement
-
Postmenopausal Hormone Therapy and Stroke
Bath and gray from the division of stroke Medicine in the Queens Medical Centre, University of Nottingham, performed a meta-analysis of the published literature regarding the association between postmenopausal hormone therapy and risk of stroke. -
High Tech Prognostication for Ovarian Cancer Patients
Given the widely variant survival characteristics of women with advanced ovarian cancer, discrete quantifiable differences in tumor biology must exist. Heretofore, accurate characterization has been elusive. -
Effects of Long-Term Vitamin E Supplementation on Cardiovascular Events and Cancer
The rationale for this study is interesting. As the trial investigators point out, oxidative injury has been implicated as a key mechanism, leading to atherosclerotic cardiovascular disease and cancer. -
Full May 2005 Issue in PDF
-
Pharmacology Watch: The FDA Pulls Another COX-2 Inhibitor Off the Market
Is Holding NSAIDs Prior to Surgery Rational?; Low-Dose Aspirin: Men vs Women; FDA Actions -
Special Feature: Contemporary Prenatal Diagnosis
In 1985 5.6% of pregnant patients were 35 years of age or older, and in 2002 that figure rose to 12.5%. It is estimated that last year 20% of the pregnant population was older than 34 years of age. -
Full May 2005 Issue in PDF